The Global Hydrocortisone Butyrate API Market was valued at USD 125.3 Million in 2023 and is projected to reach USD 182.7 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2023–2030). This growth is primarily driven by the rising global prevalence of inflammatory skin conditions such as eczema and psoriasis, increasing demand for topical corticosteroids, and the expansion of pharmaceutical manufacturing capabilities in emerging economies.

As the pharmaceutical industry focuses on quality assurance and supply chain resilience for essential Active Pharmaceutical Ingredients (APIs), the companies producing Hydrocortisone Butyrate are playing a critical role. In this report, we profile the Top 10 Companies in the Hydrocortisone Butyrate API Industry—a mix of global pharmaceutical giants and specialized API manufacturers ensuring the steady supply of this vital therapeutic compound.

---

🔟 1. Pfizer CentreOne

Headquarters: New York, New York, USA
Key Offering: High-Purity Hydrocortisone Butyrate API

Pfizer CentreOne, the contract manufacturing and API arm of Pfizer Inc., is a leading global supplier of steroids and complex APIs. Leveraging Pfizer’s extensive R&D and manufacturing expertise, it produces highly pure Hydrocortisone Butyrate that meets stringent international pharmacopeia standards (USP, EP, JP) for use in topical formulations worldwide.

Quality and Innovation Initiatives:

• State-of-the-art cGMP manufacturing facilities

• Continuous process optimization for enhanced yield and purity

• Robust global supply chain and regulatory support

Download FREE Sample Report: Hydrocortisone Butyrate API Market – View in Detailed Research Report

---

9️⃣ 2. Curia Global, Inc. (formerly AMRI)

Headquarters: Albany, New York, USA
Key Offering: Hydrocortisone Butyrate API, Custom Synthesis

Curia Global is a full-service contract research, development, and manufacturing organization with a strong track record in steroid API production. Their expertise in chemical synthesis allows them to offer high-quality Hydrocortisone Butyrate to pharmaceutical companies for branded and generic drug applications.

Quality and Innovation Initiatives:

• Integrated services from discovery to commercial manufacturing

• Focus on developing efficient and sustainable synthetic pathways

---

8️⃣ 3. Zhejiang Xianju Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Hydrocortisone Butyrate API (Purity 99% and 99.5%)

Xianju Pharmaceutical is a major Chinese manufacturer of steroid hormones and APIs. With significant production capacity and competitive pricing, the company is a key supplier in the Asian market and increasingly to global customers, supported by its adherence to international quality standards.

Quality and Innovation Initiatives:

• Vertically integrated production from basic raw materials

• Continuous investment in scaling manufacturing capabilities

---

7️⃣ 4. Tianjin Lihua Pharmaceutical Co., Ltd.

Headquarters: Tianjin, China
Key Offering: Hydrocortisone Butyrate, Corticosteroid APIs

Lihua Pharmaceutical specializes in the research, production, and sale of corticosteroid APIs. The company has established itself as a reliable manufacturer of Hydrocortisone Butyrate, focusing on consistency and quality control to serve the growing demand from generic drug manufacturers.

Quality and Innovation Initiatives:

• Strong R&D focus on process chemistry

• Strategic partnerships with global pharmaceutical distributors

---

6️⃣ 5. Wuhan Xinxinjiali Biotechnology Co., Ltd.

Headquarters: Wuhan, Hubei, China
Key Offering: High-Purity Steroid Intermediates and APIs

Xinxinjiali Biotechnology is a specialized manufacturer of steroid compounds, including Hydrocortisone Butyrate API. The company caters to both domestic and international markets, emphasizing technical expertise in the complex synthesis of steroid molecules.

Quality and Innovation Initiatives:

• Expertise in custom synthesis and impurity profiling

• Agile manufacturing for small to medium batch sizes

Download FREE Sample Report: Hydrocortisone Butyrate API Market – View in Detailed Research Report

---

5️⃣ 6. Tianyao Pharmaceuticals Co., Ltd.

Headquarters: Tianjin, China
Key Offering: Hydrocortisone Butyrate, Betamethasone, and other corticosteroids

As part of a larger pharmaceutical group, Tianyao Pharmaceuticals has substantial experience in manufacturing steroid hormones. The company produces Hydrocortisone Butyrate API that is widely used in topical creams and ointments for treating dermatological conditions.

Quality and Innovation Initiatives:

• Investment in green chemistry initiatives to reduce environmental impact

• Expansion of international regulatory filings (DMFs, CEPs)

---

4️⃣ 7. Fengchen Group Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Hydrocortisone Butyrate API and Pharmaceutical Intermediates

Fengchen Group is a chemical and pharmaceutical company with a diverse portfolio that includes corticosteroid APIs. The company supplies Hydrocortisone Butyrate to formulation manufacturers, supported by its chemical synthesis capabilities and quality management systems.

Quality and Innovation Initiatives:

• Focus on cost-effective manufacturing processes

• Building long-term supply agreements with key customers

---

3️⃣ 8. Teva Pharmaceutical Industries Ltd.

Headquarters: Tel Aviv, Israel
Key Offering: Hydrocortisone Butyrate API (for captive use and select sales)

As one of the world’s largest generic drug manufacturers, Teva has significant in-house API manufacturing capabilities. While a major portion of its Hydrocortisone Butyrate production is for its own finished dosage forms, it also supplies the API to other manufacturers, leveraging its scale and vertical integration.

Quality and Innovation Initiatives:

• Vertical integration from API to finished product ensures quality control

• Global manufacturing footprint with multiple certified facilities

---

2️⃣ 9. Mylan N.V. (now part of Viatris Inc.)

Headquarters: Canonsburg, Pennsylvania, USA
Key Offering: APIs for Generic Formulations, including corticosteroids

Viatris, formed from the combination of Mylan and Upjohn, possesses substantial API manufacturing expertise. The company’s focus on affordable medicine extends to its API division, which produces key molecules like Hydrocortisone Butyrate to support a reliable supply of generic dermatological treatments.

Quality and Innovation Initiatives:

• Commitment to expanding access to essential medicines

• Strategic API sourcing and production to mitigate supply chain risks

---

1️⃣ 10. Hovione

Headquarters: Loures, Portugal
Key Offering: High-Purity APIs, Particle Engineering, and Finished Dosage Forms

Hovione is a international company with a focus on developing and manufacturing APIs and drug products. While known for its expertise in particle size engineering, it also has the capability to produce potent APIs like Hydrocortisone Butyrate for its partners, emphasizing quality, technology, and reliability.

Quality and Innovation Initiatives:

• Leadership in Quality by Design (QbD) approaches

• Strong regulatory track record with agencies like the FDA and EMA

Get Full Report Here: Hydrocortisone Butyrate API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Hydrocortisone Butyrate API is Secure and Quality-Focused

The Hydrocortisone Butyrate API market is characterized by stable demand, but it is evolving in response to global supply chain pressures and heightened regulatory scrutiny. The emphasis is shifting towards supply chain resilience, consistent high quality, and strategic partnerships between API manufacturers and finished product companies.

📈 Key Trends Shaping the Market:

• Increasing regulatory requirements for impurity profiling and control

• Geographic diversification of API manufacturing to mitigate risks

• Growing demand for Purity 99.5% and higher-grade material

• Consolidation among API manufacturers to achieve economies of scale

Get Full Report Here: Hydrocortisone Butyrate API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical therapeutic ingredient—they are upholding the quality and reliability standards essential for global dermatological healthcare.